XELIRI

E1997511 UNEXPLORED

XELIRI is a chemotherapy regimen that combines irinotecan with the oral fluoropyrimidine capecitabine, commonly used to treat advanced colorectal cancer.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
XELIRI canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

irinotecan → isComponentOfRegimen → XELIRI ⓘ